ALMIB.PA
Price:
$1.0284
Market Cap:
$51.03M
Amoéba S.A. develops and sells biocidal and fungicide products. It is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds, and plant protection. The company was founded in 2010 and is headquartered in Chassieu, France.[Read more]
Industry
Agricultural Inputs
IPO Date
2015-07-10
Stock Exchange
EURONEXT
Ticker
ALMIB.PA
According to Amoéba S.A.’s latest financial reports and current stock price. The company's current ROE is 0.24%. This represents a change of -100.98% compared to the average of -24.95% of the last 4 quarters.
The mean historical ROE of Amoéba S.A. over the last ten years is -453.65%. The current 0.24% ROE has changed -100.05% with respect to the historical average. Over the past ten years (40 quarters), ALMIB.PA's ROE was at its highest in in the December 2023 quarter at 0.26%. The ROE was at its lowest in in the December 2021 quarter at -1836.28%.
Average
-453.65%
Median
-74.03%
Minimum
-3934.54%
Maximum
362.51%
Discovering the peaks and valleys of Amoéba S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 864.92%
Maximum Annual ROE = 362.51%
Minimum Annual Increase = -468.89%
Minimum Annual ROE = -3934.54%
Year | ROE | Change |
---|---|---|
2023 | 362.51% | -468.89% |
2022 | -98.27% | -97.50% |
2021 | -3934.54% | 864.92% |
2020 | -407.76% | 137.79% |
2019 | -171.48% | 28.46% |
2018 | -133.48% | 168.10% |
2017 | -49.79% | 60.79% |
2016 | -30.96% | -18.34% |
2015 | -37.92% | 8.90% |
2014 | -34.82% | -71.00% |
The current ROE of Amoéba S.A. (ALMIB.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1223.43%
5-year avg
-849.91%
10-year avg
-453.65%
Amoéba S.A.’s ROE is greater than Gaussin SA (0%), greater than The Blockchain Group (-178.46%), greater than Drone Volt SA (-29.43%), less than GenSight Biologics S.A. (54.11%), greater than Europlasma S.A. (-792.63%),
Company | ROE | Market cap |
---|---|---|
0% | $4.27M | |
-178.46% | $51.58M | |
-29.43% | $21.47M | |
54.11% | $29.46M | |
-792.63% | $4.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amoéba S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amoéba S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Amoéba S.A.'s ROE?
How is the ROE calculated for Amoéba S.A. (ALMIB.PA)?
What is the highest ROE for Amoéba S.A. (ALMIB.PA)?
What is the 3-year average ROE for Amoéba S.A. (ALMIB.PA)?
What is the 5-year average ROE for Amoéba S.A. (ALMIB.PA)?
How does the current ROE for Amoéba S.A. (ALMIB.PA) compare to its historical average?